4//SEC Filing
PENDARVIS DAVID 4
Accession 0001127602-23-012530
CIK 0000943819other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 3:28 PM ET
Size
4.4 KB
Accession
0001127602-23-012530
Insider Transaction Report
Form 4
RESMED INCRMD
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
- Sale
ResMed Common Stock
2023-04-03$218.23/sh−1,500$327,345→ 92,672 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022.
Documents
Issuer
RESMED INC
CIK 0000943819
Entity typeother
Related Parties
1- filerCIK 0001196723
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 3:28 PM ET
- Size
- 4.4 KB